Pralidoxime

NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 450 doses to be delivered before 31 March 2027. Optional requirements of 600 doses to be requested and delivered between 01 April 2027 and 31 March 2031. There are no security requirements associated with this requirement. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.

Category: GD

• Procurement method: Competitive - Open bidding
• Briefing session: Not captured. Check the original notice before relying on this.
• Eligibility and evaluation: set out in the tender documents. Check mandatory returnables, registrations and scoring before you commit.

The tender pack is published with the original notice. Use “Download Tender Pack” to open it.

Published

24 Sept 2026

First seen by Atlas

29 Sept 2026

Briefing session

Not captured. Check the original notice before relying on this.

Submission deadline

10 Nov 2026, 16:00 SAST

Estimated value

Not stated in the notice

Contract type

Competitive - Open bidding

Category

GD

Source

CanadaBuys

• Manage the Bid: A structured response, from the opportunity decision to the final submission.
• Develop the Response: Clear writing, considered production and approved material ready for reuse.
• Build Bid Capability: Practical support that strengthens how your business prepares and responds.